Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-026596
Filing Date
2019-11-04
Accepted
2019-11-04 17:52:12
Documents
1
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3677
  Complete submission text file 0000899243-19-026596.txt   5043
Mailing Address ONE EDWARDS WAY IRVINE CA 92614
Business Address
WEISNER AIMEE S (Reporting) CIK: 0001227308 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39112 | Film No.: 191190930

Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Issuer) CIK: 0001720725 (see all company filings)

EIN.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)